Annual total expenses:
$2.38B+$118.57M(+5.24%)Summary
- As of today (July 1, 2025), BMRN annual total expenses is $2.38 billion, with the most recent change of +$118.57 million (+5.24%) on December 31, 2024.
- During the last 3 years, BMRN annual total expenses has risen by +$459.09 million (+23.90%).
- BMRN annual total expenses is now at all-time high.
Performance
BMRN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$521.24M-$64.71M(-11.04%)Summary
- As of today (July 1, 2025), BMRN quarterly total expenses is $521.24 million, with the most recent change of -$64.71 million (-11.04%) on March 31, 2025.
- Over the past year, BMRN quarterly total expenses has dropped by -$49.13 million (-8.61%).
- BMRN quarterly total expenses is now -17.51% below its all-time high of $631.87 million, reached on September 30, 2024.
Performance
BMRN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BMRN Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.2% | -8.6% |
| 3 y3 years | +23.9% | +6.8% |
| 5 y5 years | +31.6% | +14.2% |
BMRN Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.9% | -17.5% | +5.6% |
| 5 y | 5-year | at high | +31.6% | -17.5% | +13.7% |
| alltime | all time | at high | >+9999.0% | -17.5% | +9065.4% |
BMRN Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $521.24M(-11.0%) |
| Dec 2024 | $2.38B(+5.2%) | $585.94M(-7.3%) |
| Sep 2024 | - | $631.87M(+6.8%) |
| Jun 2024 | - | $591.58M(+3.7%) |
| Mar 2024 | - | $570.37M(-7.8%) |
| Dec 2023 | $2.26B(+10.3%) | $618.90M(+21.9%) |
| Sep 2023 | - | $507.64M(-4.2%) |
| Jun 2023 | - | $529.71M(-0.8%) |
| Mar 2023 | - | $534.01M(-2.9%) |
| Dec 2022 | $2.05B(+6.7%) | $550.00M(+8.5%) |
| Sep 2022 | - | $506.82M(+2.6%) |
| Jun 2022 | - | $493.75M(+1.2%) |
| Mar 2022 | - | $488.03M(-5.1%) |
| Dec 2021 | $1.92B(-1.6%) | $514.04M(+11.7%) |
| Sep 2021 | - | $460.11M(-5.7%) |
| Jun 2021 | - | $487.87M(+6.4%) |
| Mar 2021 | - | $458.59M(-7.1%) |
| Dec 2020 | $1.95B(+7.9%) | $493.90M(-7.0%) |
| Sep 2020 | - | $530.85M(+12.8%) |
| Jun 2020 | - | $470.42M(+3.0%) |
| Mar 2020 | - | $456.63M(+0.8%) |
| Dec 2019 | $1.81B(+9.9%) | $452.97M(-0.9%) |
| Sep 2019 | - | $457.09M(+2.9%) |
| Jun 2019 | - | $444.06M(-2.3%) |
| Mar 2019 | - | $454.70M(+12.9%) |
| Dec 2018 | $1.65B(+13.3%) | $402.92M(-1.1%) |
| Sep 2018 | - | $407.45M(-2.5%) |
| Jun 2018 | - | $418.11M(+0.1%) |
| Mar 2018 | - | $417.82M(-1.7%) |
| Dec 2017 | $1.45B(+10.0%) | $425.26M(+22.2%) |
| Sep 2017 | - | $347.88M(-2.4%) |
| Jun 2017 | - | $356.26M(+10.0%) |
| Mar 2017 | - | $323.95M(-16.9%) |
| Dec 2016 | $1.32B(+12.8%) | $389.71M(+14.6%) |
| Sep 2016 | - | $339.98M(+24.2%) |
| Jun 2016 | - | $273.82M(-13.8%) |
| Mar 2016 | - | $317.65M(+6.8%) |
| Dec 2015 | $1.17B(+28.8%) | $297.42M(+2.3%) |
| Sep 2015 | - | $290.78M(-7.5%) |
| Jun 2015 | - | $314.42M(+17.0%) |
| Mar 2015 | - | $268.78M(-6.9%) |
| Dec 2014 | $909.67M(+29.3%) | $288.82M(+24.0%) |
| Sep 2014 | - | $232.85M(+10.5%) |
| Jun 2014 | - | $210.67M(+18.3%) |
| Mar 2014 | - | $178.01M(-10.2%) |
| Dec 2013 | $703.55M(+15.2%) | $198.24M(+5.7%) |
| Sep 2013 | - | $187.60M(+19.6%) |
| Jun 2013 | - | $156.86M(-2.5%) |
| Mar 2013 | - | $160.85M(-10.1%) |
| Dec 2012 | $610.94M(+28.6%) | $178.84M(+29.0%) |
| Sep 2012 | - | $138.61M(-10.6%) |
| Jun 2012 | - | $154.97M(+11.9%) |
| Mar 2012 | - | $138.51M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $475.25M(+26.5%) | $129.28M(+0.3%) |
| Sep 2011 | - | $128.94M(+13.9%) |
| Jun 2011 | - | $113.19M(+5.9%) |
| Mar 2011 | - | $106.85M(-3.9%) |
| Dec 2010 | $375.72M(+21.9%) | $111.17M(+16.1%) |
| Sep 2010 | - | $95.72M(+9.6%) |
| Jun 2010 | - | $87.33M(+6.3%) |
| Mar 2010 | - | $82.16M(+1.8%) |
| Dec 2009 | $308.23M(+20.1%) | $80.70M(+14.2%) |
| Sep 2009 | - | $70.67M(-9.9%) |
| Jun 2009 | - | $78.47M(+0.1%) |
| Mar 2009 | - | $78.38M(+16.6%) |
| Dec 2008 | $256.74M(+43.5%) | $67.22M(-4.4%) |
| Sep 2008 | - | $70.30M(+17.9%) |
| Jun 2008 | - | $59.64M(+0.1%) |
| Mar 2008 | - | $59.58M(+8.7%) |
| Dec 2007 | $178.87M(+64.3%) | $54.80M(+29.5%) |
| Sep 2007 | - | $42.31M(-0.4%) |
| Jun 2007 | - | $42.48M(+7.2%) |
| Mar 2007 | - | $39.63M(+18.0%) |
| Dec 2006 | $108.88M(+21.1%) | $33.58M(+15.6%) |
| Sep 2006 | - | $29.04M(+17.2%) |
| Jun 2006 | - | $24.79M(+15.4%) |
| Mar 2006 | - | $21.47M(-3.7%) |
| Dec 2005 | $89.88M(-46.0%) | $22.30M(+7.5%) |
| Sep 2005 | - | $20.75M(-7.4%) |
| Jun 2005 | - | $22.40M(-8.3%) |
| Mar 2005 | - | $24.43M(-74.9%) |
| Dec 2004 | $166.55M(+89.5%) | $97.45M(+263.6%) |
| Sep 2004 | - | $26.80M(+16.7%) |
| Jun 2004 | - | $22.96M(+18.8%) |
| Mar 2004 | - | $19.34M(-23.0%) |
| Dec 2003 | $87.90M(+30.0%) | $25.11M(+21.5%) |
| Sep 2003 | - | $20.67M(-4.2%) |
| Jun 2003 | - | $21.58M(+5.0%) |
| Mar 2003 | - | $20.54M(+32.8%) |
| Dec 2002 | $67.62M(+42.0%) | $15.47M(-16.9%) |
| Sep 2002 | - | $18.61M(+13.5%) |
| Jun 2002 | - | $16.40M(-4.4%) |
| Mar 2002 | - | $17.14M(+130.8%) |
| Dec 2001 | $47.63M(+4.9%) | $7.43M(-44.6%) |
| Sep 2001 | - | $13.42M(+2.9%) |
| Jun 2001 | - | $13.04M(+17.2%) |
| Mar 2001 | - | $11.13M(-15.8%) |
| Dec 2000 | $45.39M(+46.0%) | $13.22M(+19.6%) |
| Sep 2000 | - | $11.05M(+7.6%) |
| Jun 2000 | - | $10.27M(-5.2%) |
| Mar 2000 | - | $10.84M(+35.5%) |
| Dec 1999 | $31.10M(+120.6%) | $8.00M(-18.4%) |
| Sep 1999 | - | $9.80M(+27.3%) |
| Jun 1999 | - | $7.70M(+35.4%) |
| Mar 1999 | - | $5.69M |
| Dec 1998 | $14.10M | - |
FAQ
- What is BioMarin Pharmaceutical annual total expenses?
- What is the all time high annual total expenses for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual total expenses year-on-year change?
- What is BioMarin Pharmaceutical quarterly total expenses?
- What is the all time high quarterly total expenses for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly total expenses year-on-year change?
What is BioMarin Pharmaceutical annual total expenses?
The current annual total expenses of BMRN is $2.38B
What is the all time high annual total expenses for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total expenses is $2.38B
What is BioMarin Pharmaceutical annual total expenses year-on-year change?
Over the past year, BMRN annual total expenses has changed by +$118.57M (+5.24%)
What is BioMarin Pharmaceutical quarterly total expenses?
The current quarterly total expenses of BMRN is $521.24M
What is the all time high quarterly total expenses for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total expenses is $631.87M
What is BioMarin Pharmaceutical quarterly total expenses year-on-year change?
Over the past year, BMRN quarterly total expenses has changed by -$49.13M (-8.61%)